AngioSoma Launching Holiday Awareness Campaign Heart Health Focused Campaign Set to Kick Off December 1st, 2018 HOUSTON, TX, Nov. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – AngioSoma (OTC: SOAN), a leading biotechnology research and...

StemStrength Deluxe Now Available on Amazon.com SomaCeuticals, an AngioSoma Inc. Subsidiary, Leverages Online Retail Giant for New Deluxe Formula of its Flagship Product HOUSTON, TX, Oct. 22, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE –...

AngioSoma, Inc. Announces Selection of Regulatory Firm for Flagship Drug HOUSTON, TX, June 18, 2018 (GLOBE NEWSWIRE) -- AngioSoma, Inc. (SOAN) is excited to announce that we have identified a regulatory firm who can assist taking our patented flagship drug, Liprostin™,...

AngioSoma, Inc. Announces Grant of Patent for Flagship Drug HOUSTON, TX, May 14, 2018 (GLOBE NEWSWIRE) -- AngioSoma, Inc. (OTC: SOAN) is excited to announce that the U.S. Patent Office has agreed to grant our patent application for our flagship...